FRES
Price
$1.38
Change
-$0.15 (-9.80%)
Updated
Sep 16, 02:59 PM (EDT)
KZIA
Price
$0.35
Change
+$0.01 (+2.94%)
Updated
Sep 16, 11:36 AM (EDT)
Ad is loading...

FRES vs KZIA

Header iconFRES vs KZIA Comparison
Open Charts FRES vs KZIABanner chart's image
Fresh2 Group
Price$1.38
Change-$0.15 (-9.80%)
Volume$200
CapitalizationN/A
Kazia Therapeutics
Price$0.35
Change+$0.01 (+2.94%)
Volume$93.4K
CapitalizationN/A
View a ticker or compare two or three
FRES vs KZIA Comparison Chart
Loading...
KZIA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
FRES vs. KZIA commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRES is a Hold and KZIA is a StrongSell.

COMPARISON
Comparison
Sep 16, 2024
Stock price -- (FRES: $1.53 vs. KZIA: $0.34)
Brand notoriety: FRES and KZIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FRES: 64% vs. KZIA: 8%
Market capitalization -- FRES: $3.75M vs. KZIA: $11.42M
FRES [@Biotechnology] is valued at $3.75M. KZIA’s [@Biotechnology] market capitalization is $11.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $606.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FRES’s FA Score shows that 1 FA rating(s) are green whileKZIA’s FA Score has 0 green FA rating(s).

  • FRES’s FA Score: 1 green, 4 red.
  • KZIA’s FA Score: 0 green, 5 red.
According to our system of comparison, KZIA is a better buy in the long-term than FRES.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KZIA’s TA Score shows that 3 TA indicator(s) are bullish.

  • KZIA’s TA Score: 3 bullish, 6 bearish.

Price Growth

FRES (@Biotechnology) experienced а -17.30% price change this week, while KZIA (@Biotechnology) price change was -7.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.56%. For the same industry, the average monthly price growth was +4.67%, and the average quarterly price growth was -1.44%.

Reported Earning Dates

FRES is expected to report earnings on May 16, 2023.

Industries' Descriptions

@Biotechnology (+2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KZIA($11.4M) has a higher market cap than FRES($3.75M). KZIA YTD gains are higher at: -21.934 vs. FRES (-82.810). KZIA has higher annual earnings (EBITDA): -17.52M vs. FRES (-131.06M). FRES has higher revenues than KZIA: FRES (17M) vs KZIA (0).
FRESKZIAFRES / KZIA
Capitalization3.75M11.4M33%
EBITDA-131.06M-17.52M748%
Gain YTD-82.810-21.934378%
P/E RatioN/AN/A-
Revenue17M0-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
KZIA: Fundamental Ratings
KZIA
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KZIA
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
86%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
KZIA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGLAX40.250.31
+0.78%
Lord Abbett Growth Leaders A
AOTIX29.760.22
+0.74%
Virtus EM Opps Instl
EITEX41.920.26
+0.62%
Parametric Tax-Managed Emerg Mkt I
AGRYX139.030.78
+0.56%
AB Growth Advisor
MINAX9.440.01
+0.11%
Madison International Stock A

FRES and

Correlation & Price change

A.I.dvisor indicates that over the last year, FRES has been closely correlated with HOOK. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if FRES jumps, then HOOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FRES
1D Price
Change %
FRES100%
-9.47%
HOOK - FRES
75%
Closely correlated
-2.16%
KZIA - FRES
57%
Loosely correlated
-0.98%
NKTR - FRES
34%
Loosely correlated
+4.80%
QURE - FRES
32%
Poorly correlated
+2.17%
KPRX - FRES
31%
Poorly correlated
+1.10%
More